Medicare Enrolled
Dr. John Kalin, MD
Cardiovascular Disease · Hyannis, MA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kalin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kalin
Dr. John Kalin is a cardiovascular disease specialist in Hyannis, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalin performed 8,175 Medicare services across 4,523 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kalin received a total of $542,737 from 41 pharmaceutical and/or device companies across 1200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kalin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in MA
$542,737 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,175
Medicare services
Top 2% in MA for cardiovascular disease
4,523
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~409 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,620 | $11 | $67 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,529 | $95 | $345 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
618 | $20 | $87 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
617 | $42 | $60 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
505 | $9 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
470 | $154 | $665 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
394 | $44 | $100 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
368 | $148 | $185 |
| Heart muscle strain imaging | 310 | $31 | $129 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
290 | $18 | $100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
230 | $51 | $267 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
222 | $370 | $1,539 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $70 | $237 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
202 | $23 | $99 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
95 | $125 | $510 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
92 | $26 | $190 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
87 | $54 | $415 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
54 | $65 | $228 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
46 | $296 | $1,050 |
| Technetium Tc-99m pyrophosphate diagnostic injection A diagnostic injection of Technetium Tc-99m pyrophosphate used for imaging studies. The dose administered is up to 25 millicuries. |
44 | $19 | $185 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
41 | $229 | $774 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
28 | $40 | $129 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
23 | $3,744 | $13,782 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
20 | $55 | $184 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
14 | $10 | $50 |
| New patient office visit, complex (60-74 min) | 14 | $169 | $650 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
13 | $21 | $80 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $171 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.8% high complexity
19.7% medium
66.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$542,737
Total received (2018-2024)
Avg $77,534/year across 7 years
Top 1% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,200
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$516,840 (95.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,629 (3.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,268 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$72,571
2023
$46,169
2022
$40,831
2021
$75,325
2020
$59,807
2019
$131,310
2018
$116,725
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lexicon Pharmaceuticals, Inc.
$41,301
Janssen Pharmaceuticals, Inc
$11,572
E.R. Squibb & Sons, L.L.C.
$8,775
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,586
Lilly USA, LLC
$3,761
AstraZeneca Pharmaceuticals LP
$811
Novartis Pharmaceuticals Corporation
$404
PFIZER INC.
$199
SCPHARMACEUTICALS INC.
$169
Amgen Inc.
$168
Merck Sharp & Dohme LLC
$142
Novo Nordisk Inc
$105
Actelion Pharmaceuticals US, Inc.
$95
iRhythm Technologies, Inc.
$92
Alnylam Pharmaceuticals Inc.
$85
Baxter Healthcare
$56
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$56
Sensible Medical Innovations Inc
$41
ABIOMED
$38
Esperion Therapeutics, Inc.
$33
Boston Scientific Corporation
$31
HEARTFLOW, INC.
$31
MEDICOMP INC
$22
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$156,610
E.R. Squibb & Sons, L.L.C.
$64,630
Boehringer Ingelheim Pharmaceuticals, Inc.
$64,531
Amgen Inc.
$59,393
Novartis Pharmaceuticals Corporation
$50,891
Lexicon Pharmaceuticals, Inc.
$41,375
PFIZER INC.
$28,501
AstraZeneca Pharmaceuticals LP
$26,481
Lilly USA, LLC
$17,603
AstraZeneca UK Limited
$13,338
Amarin Pharma Inc.
$6,882
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,892
Boston Scientific Corporation
$3,396
BOSTON SCIENTIFIC CORPORATION
$876
Merck Sharp & Dohme LLC
$417
Alnylam Pharmaceuticals Inc.
$347
SCPHARMACEUTICALS INC.
$258
Regeneron Healthcare Solutions, Inc.
$233
Medtronic, Inc.
$218
Bayer HealthCare Pharmaceuticals Inc.
$197
Medtronic Vascular, Inc.
$178
Gilead Sciences, Inc.
$157
Kowa Pharmaceuticals America, Inc.
$135
Novo Nordisk Inc
$129
Esperion Therapeutics, Inc.
$122
iRhythm Technologies, Inc.
$122
Bardy Diagnostics, Inc.
$110
Actelion Pharmaceuticals US, Inc.
$95
Kiniksa Pharmaceuticals, Ltd.
$79
Abbott Laboratories
$78
Merck Sharp & Dohme Corporation
$74
SANOFI-AVENTIS U.S. LLC
$69
Baxter Healthcare
$56
Bayer Healthcare Pharmaceuticals Inc.
$48
Sensible Medical Innovations Inc
$41
ABIOMED
$38
Philips Electronics North America Corporation
$35
HEARTFLOW, INC.
$31
Janssen Scientific Affairs, LLC
$29
Covidien LP
$22
MEDICOMP INC
$22
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · Arcalyst · Azure · BRILINTA · CAMZYOS · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · FARXIGA · FFRct · FUROSCIX · GENERAL THERAPIES · Hillrom - Cardiac Ambulatory Monitor · Impella · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINQ II · LOKELMA · LifeVest · Livalo · MITRACLIP · MOUNJARO · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REVEAL LINQ · Ranexa · ReDS system · Repatha · Reveal LINQ · TELEPATCH CARDIAC MONITOR · TYRX · UPTRAVI · V-Loc · VERQUVO · VYNDAQEL · Valve Repair Flexible Rings and Bands · Vascepa · WATCHDOG · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in MA.
Geographic Context
Cardiologists within 10 mi
45
Per 100K population
19.6
County median income
$94,452
Nearest hospital
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kalin is an electrophysiology & remote specialist, with above-average Medicare volume (top 2% in MA), with speaking/promotional industry engagement in the top 1% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kalin experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Kalin performed 1,620 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalin receive payments from pharmaceutical companies?
Yes. Dr. Kalin received a total of $542,737 from 41 companies across 1,200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalin's costs compare to other cardiologists in Hyannis?
Dr. Kalin's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Hyannis
Browse cardiologists in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology